Request Deal Involvement

Sino Biopharmaceutical to acquire a 60% stake in Softhale from New Rhein Healthcare Investors for $110m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Guggenheim Partners

financial advisors

Guggenheim Partners

Theraproval

legal advisors

Theraproval

Ernst & Young

financial advisors

Ernst & Young

Results Healthcare

financial advisors

Results Healthcare

Baker McKenzie

legal advisors

Baker McKenzie

Carpmaels & Ransford

financial advisors

Carpmaels & Ransford

or

Principals

SOFTHALE

target

SOFTHALE

SINO BIOPHARMACEUTICAL

bidder

SINO BIOPHARMACEUTICAL

NEW RHEIN HEALTHCARE INVESTORS LLC

vendor

NEW RHEIN HEALTHCARE INVESTORS LLC

PM EQUITY PARTNER

vendor

PM EQUITY PARTNER

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite